Menu
GeneBe

1-171783839-A-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_015935.5(METTL13):c.253A>G(p.Lys85Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )

Consequence

METTL13
NM_015935.5 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.42
Variant links:
Genes affected
METTL13 (HGNC:24248): (methyltransferase 13, eEF1A N-terminus and K55) Predicted to enable methyltransferase activity. Involved in negative regulation of cell cycle G1/S phase transition and negative regulation of transcription by RNA polymerase II. Predicted to be located in mitochondrion and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.06202376).
BS2
High AC in GnomAdExome at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
METTL13NM_015935.5 linkuse as main transcriptc.253A>G p.Lys85Glu missense_variant 2/8 ENST00000361735.4
METTL13NM_001007239.2 linkuse as main transcriptc.253A>G p.Lys85Glu missense_variant 2/8
METTL13NM_014955.3 linkuse as main transcriptc.-6A>G 5_prime_UTR_variant 2/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
METTL13ENST00000361735.4 linkuse as main transcriptc.253A>G p.Lys85Glu missense_variant 2/81 NM_015935.5 P1Q8N6R0-5
METTL13ENST00000367737.9 linkuse as main transcriptc.253A>G p.Lys85Glu missense_variant 2/81 Q8N6R0-1
METTL13ENST00000362019.7 linkuse as main transcriptc.-6A>G 5_prime_UTR_variant 2/82 Q8N6R0-3
METTL13ENST00000485629.1 linkuse as main transcriptn.365A>G non_coding_transcript_exon_variant 3/45

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152192
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000199
AC:
5
AN:
251490
Hom.:
0
AF XY:
0.0000147
AC XY:
2
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000684
AC:
10
AN:
1461894
Hom.:
0
Cov.:
31
AF XY:
0.00000550
AC XY:
4
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.000344
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152192
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74346
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.0000165
AC:
2
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 05, 2023The c.253A>G (p.K85E) alteration is located in exon 2 (coding exon 2) of the METTL13 gene. This alteration results from a A to G substitution at nucleotide position 253, causing the lysine (K) at amino acid position 85 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.097
T
BayesDel_noAF
Benign
-0.38
Cadd
Benign
21
Dann
Uncertain
1.0
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.78
T;D
M_CAP
Benign
0.0097
T
MetaRNN
Benign
0.062
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.18
N;N
MutationTaster
Benign
1.0
D;N;N;N
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-2.0
N;N
REVEL
Benign
0.087
Sift
Benign
0.39
T;D
Sift4G
Benign
0.16
T;T
Polyphen
0.073
B;P
Vest4
0.21
MutPred
0.45
Loss of methylation at K85 (P = 0.0366);Loss of methylation at K85 (P = 0.0366);
MVP
0.48
MPC
0.37
ClinPred
0.20
T
GERP RS
3.9
Varity_R
0.23
gMVP
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs749884051; hg19: chr1-171752979; API